Lung Cancer: Targets and Therapy : Impact Factor & More
eISSN: 1179-2728pISSN: 1179-2728
Open AccessShare this on:
Key Metrics
CiteScore 
6.5
SNIP
1.15
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Lung Cancer: Targets and Therapy Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | DOVE MEDICAL PRESS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2390 |
| Publication Time | 16 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2008 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Lung Cancer: Targets and Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Lung Cancer: Targets and Therapy
HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib \u2013 A Case Report
- 14 May 2026
- Lung Cancer: Targets and Therapy
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer
- 8 May 2026
- Lung Cancer: Targets and Therapy
Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients
- 16 Mar 2026
- Lung Cancer: Targets and Therapy
Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China.
- 1 Feb 2026
- Lung Cancer (Auckland, N.Z.)
Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung Cancer
- 6 Jan 2026
- Lung Cancer: Targets and Therapy
Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
- 25 Dec 2025
- Lung Cancer: Targets and Therapy
HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib \u2013 A Case Report
- 14 May 2026
- Lung Cancer: Targets and Therapy
Exploratory Identification of Gene Copy Number Cut-Off for NGS-Based MET Amplification Assessment and Clinical Relevance to MET Inhibitor Outcomes in Non-Small-Cell Lung Cancer
- 8 May 2026
- Lung Cancer: Targets and Therapy
Efficiency of Immunological Blood Biomarkers in Predicting Chemotherapy Response and Survival Outcome for Non-Targetable Advanced Non-Small Cell Lung Cancer Patients
- 16 Mar 2026
- Lung Cancer: Targets and Therapy
Prospective Observational Real-World Study of Afatinib as First-Line Treatment in Patients with Epidermal Growth Factor Receptor (EGFR) Mutation-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) in China.
- 1 Feb 2026
- Lung Cancer (Auckland, N.Z.)
Reduced Claudin-3 Expression Is Linked to Unfavorable Tumor Features and Poor Prognosis in Non-Small Cell Lung Cancer
- 6 Jan 2026
- Lung Cancer: Targets and Therapy
Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
- 25 Dec 2025
- Lung Cancer: Targets and Therapy
FAQs on Lung Cancer: Targets and Therapy
How long has Lung Cancer: Targets and Therapy been actively publishing? 
What is the publishing frequency of Lung Cancer: Targets and Therapy?
How many articles did Lung Cancer: Targets and Therapy publish last year?
What is the eISSN & pISSN for Lung Cancer: Targets and Therapy?
What is Citescore for Lung Cancer: Targets and Therapy?
What is SNIP score for Lung Cancer: Targets and Therapy?
Who is the publisher of Lung Cancer: Targets and Therapy?
Check if your manuscript is a good match for
undefined
Upload your manuscript to get recommendations of journals
that have published papers similar to your manuscript
Drag and drop your file here
We accept manuscripts in English. File format: .doc and .docx | Maximum size: 10 MB | Word count: 200-300,000 words | File length: less than 100 pages
Do not have a manuscript right now? Use an abstract or summary
Your document is 100% secure & confidential We use 256-bit encryption for total security and
ISO/IEC 27001:2013 Certified
What all does the report include
01. Degree of Match
02. Common Topics
03. Additional
Recommendations
Recommendations